Fundamentals and health benefits of xanthohumol, a natural product derived from hops and beer

Natural Product Communications

Volumn 4, Issue 5, 2009, Pages 591-610

  Magalhães, Paulo J ^a   Carvalho, Daniel O ^a   Cruz, José M ^b   Guido, Luís F ^a   Barros, Aquiles A ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b IBESA Instituto de Bebidas e Saú   (Portugal)

Author keywords

Beer; Health; Hops; Polyphenols; Xanthohumol

Indexed keywords

6 PRENYLNARINGENIN; ANTIFUNGAL AGENT; CARBOHYDRATE; CARBONYL DERIVATIVE; CARBOXYLIC ACID; CHALCONARINGENIN; CHALCONE DERIVATIVE; CHLOROQUINE; CIPROFLOXACIN; DESMETHYLXANTHOHUMOL; FLAVONOID; GENISTEIN; GRISEOFULVIN; HONOKIOL; HUMULON; HYDROCARBON; ISOXANTHOHUMOL; LUPULON; NARINGENIN; NEOSPORIN; PHENOL DERIVATIVE; PLANT EXTRACT; POLYMYXIN B; POLYPHENOL DERIVATIVE; QUERCETIN; RESIN; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN; XANTHOHUMOL;

ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ATHEROSCLEROSIS; BEER; BIOTECHNOLOGY; BREAST CANCER; BREWING; CANCER CELL CULTURE; COLON CANCER; COOLING; CYTOMEGALOVIRUS; DRUG BIOAVAILABILITY; DRUG POTENTIATION; FILTRATION; FUNGUS; HEALTH; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOPS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERTRIGLYCERIDEMIA; KAPOSI SARCOMA; LIPID PEROXIDATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OBESITY; OVARY CANCER; PASTEURIZATION; PLASMODIUM FALCIPARUM; PROSTATE CANCER; REVIEW; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SALIVARIUS; STREPTOCOCCUS SANGUINIS; VIRUS REPLICATION;

HUMULUS;

EID: 76749163955     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0900400501     Document Type: Review

References (147)

1. Ramírez SC, Castro MMB, Carretero AS, Blanco CC, Gutiérrez AF. (2003) Analysis of beer components by capillary electrophoretic methods. Trends in Analytical Chemistry, 22, 440-455.
2. Kratky R, Buiatti S. (2008) Beer in Health and Disease Prevention. In The chemical nature of flavor in beer, Chapter 7, Preedy VR (Ed). Elsevier Science & Technology, London, UK, 73-84.
3. Gerhäuser C, Alt A, Heiss E, Gamal-Eldeen A, Klimo K, Knauft J, Neumann I, Scherf HR, Frank N, Bartsch H, Becker H. (2002) Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Molecular Cancer Therapeutics, 1, 959-969.
4. Gerhäuser C. (2005) Beer constituents as potential cancer chemopreventive agents. European Journal of Cancer, 41, 1941-1954. (Pubitemid 41557680)
5. Gerhäuser C. (2005) Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites. Molecular Nutrition & Food Research, 49, 827-831.
6. Wünderlich S, Zürcher A, Back W. (2005) Enrichment of xanthohumol in the brewing process. Molecular Nutrition & Food Research, 49, 874-881.
7. De Keukeleire D. (2000) Fundamentals of beer and hop chemistry. Química Nova, 23, 108-112.
8. Goldammer T. (2008) The Brewers' Handbook: the Complete Book to Brewing Beer. Apex Publishers, Virginia, USA, 1-496.
9. European Brewery Convention (EBC). (2000) Malting Technology - Manual of Good Practice. In The overall process; Raw materials; The processes. Fachverlag Hans Carl, Nürnberg, Germany, 7-48.
10. Guido LF, Rajendram R, Barros AA. (2008) Beer in Health and Disease Prevention. In Pitching yeast and beer flavor, Chapter 3, Preedy VR (Ed). Elsevier Science & Technology, London, UK, 22-32.
11. Hough JS, Briggs DE, Stevens R, Young TW. (1982) Malting and Brewing Science - Volume 2 - Hopped Wort and Beer. Chapman and Hall, New York, USA, 1-387.
12. U.S. Department of Agriculture, Agricultural Research Service (2003) USDA National Nutrient Database for Standard Reference, Release 16. Nutrient Data Laboratory Homepage: http://www.nal.usda.gov/fnic/foodcomp.
13. Duarte I, Barros A, Belton PS, Righelato R, Spraul M, Humpfer E, Gil AM. (2002) High-resolution nuclear magnetic resonance spectroscopy and multivariate analysis for the characterization of beer. Journal of Agricultural and Food Chemistry, 50, 2475-2481. (Pubitemid 34437354)
14. Gross MG Lebrón MR, Marcos A. (2000) Revisión bibliográfica sobre los efectos del consumo moderado de cerveza sobre la salud. Estudio 6. Centro de información "Cerveza y Salud".
15. Rodrigues J, Almeida P. (2008) Beer in Health and Disease Prevention. In E-2 nonenal and â-damascenone in beer, Chapter 38, Preedy VR (Ed). Elsevier Science & Technology, London, UK, 395-402.
16. Yu J, Vasanthum T, Temelli F. (2001) Analysis of phenolic acids in barley by high-performance liquid chromatography. Journal of Agricultural and Food Chemistry, 49, 4352-4358. (Pubitemid 32896436)
17. Montanari L, Perretti G, Natella F, Guidi A, Fantozzi P. (1999) Organic and phenolic acids in beer. Lebensmittel-Wissenschaft und- Technologie, 32, 535-539.
18. Gerhäuser C, Becker H. (2008) Beer in Health and Disease Prevention. In Phenolic compounds in beer, Chapter 12, Preedy VR (Ed). Elsevier Science & Technology, London, UK, 124-144.
19. Madigan D, McMurrough I, Smyth MR. (1994) Determination of proanthocyanidins and catechins in beer and barley by high-performance liquid chromatography with dual-electrode electrochemical detection. Analyst, 119, 863-868. (Pubitemid 24186197)
20. Stevens JF, Taylor AW, Chawson JE, Deinzer ML. (1999) Fate of xanthohumol and related prenylflavonoids from hops to beer. Journal of Agricultural and Food Chemistry, 47, 2421-2428.
21. Stevens JF, Taylor AW, Deinzer ML. (1999) Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography - tandem mass spectrometry. Journal of Chromatography A, 832, 97-107. (Pubitemid 29073728)
22. Ceh B, Kac M, Kosir IJ, Abram V. (2007) Relationships between xanthohumol and polyphenol content in hop leaves and hop cones with regard to water supply and cultivar. International Journal of Molecular Sciences, 8, 989-1000. (Pubitemid 47523245)
23. Magalhães PJ, Dostalek P, Cruz JM, Guido LF, Barros AA. (2008) The impact of a xanthohumol-enriched hop product on the behavior of xanthohumol and isoxanthohumol in pale and dark beer: a pilot scale approach. Journal of the Institute of Brewing, 114, 246-256.
24. Magalhães PJ, Guido LF, Cruz JM, Barros AA. (2007) Analysis of xanthohumol and isoxanthohumol in different hop products by liquid chromatography-diode array detection-electrospray ionization tandem mass spectrometry. Journal of Chromatography A, 1150, 295-301. (Pubitemid 46678955)
25. Biendl M, Pinzl C. (2008) Hops and Health. In Effects - Efficacy of individual hop components, Chapter 4, German Hop Museum, Wolnzach, Germany, 49-76.
26. Callemien D, Jerkovic V, Rozenberg R, Collin S. (2005) Hop as an interesting source of resveratrol for brewers: Optimization of the extraction and quantitative study by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. Journal of Agricultural and Food Chemistry, 53, 424-429. (Pubitemid 40129936)
27. Stevens JF, Page JE. (2004) Xanthohumol and related prenylflavonoids from hops and beer: to your good health. Phytochemistry, 65, 1317-1330.
28. De Keukeleire J, Janssens I, Heyerick A, Ghekiere G, Cambie J, Roldán-Ruiz I, Van Bockstaele E, De Keukeleire D. (2007) Relevance of organic farming and effect of climatological conditions on the formation of α-acids, β-acids, desmethylxanthohumol, and xanthohumol in hop (Humulus lupulus L.). Journal of Agricultural and Food Chemistry, 55, 61-66. (Pubitemid 46059122)
29. Hee JJ, Sam SK, Sook KH, Jae SC. (2005) In vitro free radical and ONOO- scavengers from Sophora flavescens. Archives of Pharmacal Research, 28, 534-540.
30. Biendl M, Methner FJ, Stettner G, Walker CJ. (2004) Brewing trials with a xanthohumol-enriched hop product. Brauwelt International, 22, 182-184.
31. Biendl M, Mitter W, Peters U. (2002) Use of a xanthohumol-rich hop product in beer production. Brauwelt International, 20, 39-42.
32. Back W, Zürcher A, Wünderlich S. (2004) Enrichment of xanthohumol in the brewing process. Patent publication number DE 102 56 166 A1.
33. Stettner G, Methner FJ, Biendl M. (2003) Use of a new xanthohumol-rich hop product in the brewhouse - fate of xanthohumol during beer production and influence of non specific hop compounds on the bitterness of beer. Proceedings of the European Brewing Convention Congress, Dublin, Verlag Hans Carl Getränke-Fachverlag: Nürnberg, 1383-1389.
34. Winkelmann L, Schütze M. (2004) Highly innovative products rich in xanthohumol. Brauwelt International, 5, 300-301.
35. Biendl M. (2007) Commercial hop extracts rich in xanthohumol. Proceedings of the Scientific Commission of International Hop Grower's Convention, Germany, 12.
36. Forster A, Gahr A, Ketterer M, Beck B, Massinger S. (2002) Xanthohumol in beer - possibilities and limitations of enrichment. Monatsschrift Fur Brauwissenschaft, 55, 184-194. (Pubitemid 35281565)
37. Kondo K. (2004) Beer and health: preventive effects of beer components on lifestyle-related diseases. Biofactors, 22, 303-310.
38. Kristiansen L, Gronbaek M, Becker U, Tolstrup JS. (2008) Risk of pancreatitis according to alcohol drinking habits: a populationbased cohort study. American Journal of Epidemiology, 168, 932-937.
39. Mantena SK, King AL, Andringa KK, Eccleston HB, Bailey SM. (2008) Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol - and obesity-induced fatty liver diseases. Free Radical Biology and Medicine, 44, 1259-1272.
40. Ponicki WR, Gruenewald PJ. (2006) The impact of alcohol taxation on liver cirrhosis mortality. Journal of Studies on Alcohol, 67, 934-938. (Pubitemid 44595149)
41. Bongaerts BW, Van den Brandt PA, Goldbohm RA, De Goeij AF, Weijenber MP. (2008) Alcohol consumption, type of alcoholic beverage and risk of colorectal cancer at specific subsites. International Journal of Cancer, 123, 2411-2417.
42. Pelucchi C, Gallus S, Garavello W, Bosetti C, La Vecchia C. (2008) Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. European journal of cancer prevention: the official journal of the European Cancer Prevention Organization (ECP), 17, 340-344.
43. Deandrea S, Talamini R, Foschi R, Montella M, Dal Maso L, Falcini F, La Vecchia C, Franceschi S, Negri E. (2008) Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: A case-control study. Cancer Epidemiology Biomarkers and Prevention, 17, 2025-2028.
44. Strother WN, Lumeng L, McBride WJ. (2008) Acute ethanol effects on local cerebral glucose utilization in select central nervous system regions of adolescent alcohol-preferring (P) and alcohol-nonpreferring (NP) rats. Alcoholism Clinical and Experimental Research, 32, 1875-1883.
45. Alderazi Y, Brett F. (2007) Alcohol and the nervous system. Current Diagnostic Pathology, 13, 203-209.
46. Li XM, Deng Y. (2005) Alcohol abuse in the injury of central nervous system. Chinese Journal of Clinical Rehabilitation, 9, 181-183. (Pubitemid 41575651)
47. Huntgeburth M, ten Freyhaus H, Rosenkranz S. (2005) Alcohol consumption and hypertension. Current Hypertension Reports, 7, 180-185.
48. Miller PM, Anton RF, Egan BM, Basile J, Nguyen SA. (2005) Excessive alcohol consumption and hypertension: clinical implications of current research. Journal of clinical hypertension (Greenwich, Conn), 7, 346-351.
49. Lang CH, Frost RA, Summer AD, Vary TC. (2005) Molecular mechanisms responsible for alcohol-induced myopathy in skeletal muscle and heart. International Journal of Biochemistry and Cell Biology, 37, 2180-2195. (Pubitemid 41206830)
50. Wannamethee SG, Camargo CA, Manson JE, Willett WC, Rimm EB. (2003) Alcohol drinking patterns and risk of type 2 diabetes mellitus among younger women. Archives of Internal Medicine, 163, 1329-1336.
51. Sakuta H, Suzuki T, Ito T, Yasuda H. (2007) Beer ethanol consumption and plasma homocysteine among patients with type 2 diabetes. Diabetes Research and Clinical Practice, 78, 202-207. (Pubitemid 47451526)
52. Beulens JW, de Zoete EC, Kok FJ, Schaafsma G, Hendricks HF. (2008) Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: a diet intervention study. European Journal of Clinical Nutrition, 62, 1098-1105.
53. De Luis DA, Fernandez N, Aller R, De Luis J, Arranz M, Izaola O. (2003) Relation between total homocysteine levels and beer intake in patients with diabetes mellitus type 2. Annals of Nutrition and Metabolism, 47, 119-123. (Pubitemid 36578802)
54. Jugdaohsingh R, O'Connell MA, Srioanyakorn S, Powell JJ. (2006) Moderate alcohol consumption and increased bone mineral density: potential ethanol and non-ethanol mechanisms. Proceedings of the Nutrition Society, 65, 291-310. (Pubitemid 46323843)
55. Tobe H, Muraki Y, Kitamura K, Komiyama O, Sato Y, Sugioka T, Maruyama HB, Matsuda E, Nagai M. (1997) Bone resorption inhibitors from hop extract. Bioscience Biotechnology & Biochemistry, 61, 158-169.
56. Wright CA, Bruhn CM, Heymann H, Bamforth CW. (2008) Beer and wine consumers' perceptions of the nutritional value of alcoholic and nonalcoholic beverages. Journal of Food Science, 73, H8-H11.
57. Schröder H, Masabeu A, Marti MJ, Cols M, Lisbona JM, Romagosa C, Carión T, Vilert E, Marrugat J. (2007) Myocardial infarction and alcohol consumption: a population-based case-control study. Nutrition, Metabolism and Cardiovascular Diseases, 17, 609-615. (Pubitemid 47307389)
58. Brenner H, Rothenbacher D, Bode G, März W, Hoffmeister A, Koenig W. (2001) Coronary heart disease risk reduction in a predominantly beer-drinking population. Epidemiology, 12, 390-395. (Pubitemid 32566480)
59. Mennen LI, Courcy GP, Guilland JC, Ducros V, Zarebska M, Bertrais S, Favier A, Hercberg S, Galan P. (2003) Relation between homocysteine concentrations and the consumption of different types of alcoholic beverages: the supplementation with antioxidant vitamins and minerals study. American Journal of Clinical Nutrition, 78, 334-338. (Pubitemid 39655241)
60. Mukamal KJ, Chung H, Jenny NS, Kuller LH, Longstreth Jr WT, Mittleman MA, Burke GL, Cushman M, Psaty BM, Siscovick DS. (2006) Alcohol consumption and risk of coronary disease in older adults: the cardiovascular health study. Journal of the American Geriatrics Society, 54, 30-37.
61. Gorinstein S, Caspi A, Zemser M, Libman I, Goshev I, Trakhtenberg S. (2003) Plasma circulating fibrinogen stability and moderate beer consumption. Journal of Nutritional Biochemistry, 14, 710-716. (Pubitemid 38019049)
62. Aoshima H, kar Hossain J, Koda H, Kiso Y. (2008) Beer in Health and Disease Prevention. In Beer and GABA receptors, Chapter 18, Preedy VR (Ed). Elsevier Science & Technology, London, UK, 193-201.
63. Ruitenberg A, van Swieten JC, Witteman JC, Mehta KM, van Duijn CM, Hofman A, Breteler MM. (2002) Alcohol consumption and risk of dementia: the Rotterdam study. Lancet, 359, 281-286. (Pubitemid 34119290)
64. Peters R, Peters J, Warner J, Beckett N, Bulpitt C. (2008) Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age and Ageing, 37, 505-512.
65. González-Muñoz MJ, Peña A, Meseguer I. (2008) Role of beer as a possible protective factor in preventing Alzheimer's disease. Food and Chemical Toxicology, 46, 49-56. (Pubitemid 350235751)
66. Peña A, Meseguer I, González-Muñoz MJ. (2007) Influence of moderate beer consumption on aluminium toxicokynetics: acute study. Nutricion Hospitalaria, 22, 371-376.
67. Hernán MA, Chen H, Schwarzschild MA, Ascherio A. (2003) Alcohol consumption and the incidence of Parkinson's disease. Annals of Neurology, 54, 170-175. (Pubitemid 36909616)
68. Rodriguez RJ, Miranda CL, Stevens JF, Deinzer ML, Buhler DR. (2001) Influence of prenylated and non-prenylated flavonoids on liver microsomal lipid peroxidation and oxidative injury in rat hepatocytes. Food and Chemical Toxicology, 39, 437-445.
69. Vinson JA, Mandarano M, Hirst M, Trevithick JR, Bose P. (2003) Phenol antioxidant quantity and quality in foods: beers and the effects of two types of beer on an animal model of atherosclerosis. Journal of Agricultural and Food Chemistry, 51, 5528-5533.
70. Gorinstein S, Caspi A, Powelzik E, Delgado-Licon E, Libman I, Trakhtenberg S, Weisz M, Martin-Belloso O. (2001) Proteins of beer affect lipid levels in rats. Nutrition Research, 21, 1159-1169. (Pubitemid 32905728)
71. Sierksma A, van der Gaag MS, Kluft C, Hendriks HF. (2002) Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomizes, diet-controlled intervention study. European Journal of Clinical Nutrition, 56, 1130-1136. (Pubitemid 35414800)
72. Fiotti N, Tubaro F, Altamura N, Grassi G, Moretti M, Dapas B, Farra R, Mizzau M, Guarnieri G, Buiatti S, Giansante C. (2008) Alcohol reduces MMP-2 in humans and isolated smooth muscle cells. Alcohol, 42, 389-395.
73. Tousoulis D, Ntarladimas I, Antoniades C, Vasiliadou C, Tentolouris C, Papageorgiou N, Latsios G, Stefanadis C. (2008) Acute effects of different alcoholic beverages on vascular endothelium, inflammatory markers and thrombosis fibrinolysis system. Clinical Nutrition, 27, 594-600.
74. Imhof A, Blagieva R, Marx N, Koenig W. (2008) Drinking modulates monocyte migration in healthy subjects: a randomized intervention study of water, red wine and beer with or without alcohol. Diabetes and Vascular Disease Research, 5, 48-53. (Pubitemid 351507346)
75. Bamforth CW. (2002) Nutritional aspects of beer - a review. Nutrition Research, 22, 227-237.
76. Jain MG, Hislop GT, Howe GR, Burch JD, Ghadirian P. (1998) Alcohol and other beverage use and prostate cancer risk among Canadian men. International Journal of Cancer, 78, 707-711.
77. Parker AS, Cerhan JR, Lynch CF, Ershow AG, Cantor KP. (2002) Gender, alcohol consumption, and renal cell carcinoma. American Journal of Epidemiology, 155, 455-462. (Pubitemid 34174157)
78. Tsugane S, Fahe MT, Sasaki S, Baba S. (1999) Alcohol consumption and all-cause and cancer mortality among middle aged Japanese men: seven-year follow-up of the JPHC study Cohort I. Japan Public Health Center. American Journal of Epidemiology, 150, 1201-1207.
79. Nozawa H, Yoshida A, Tajima O, Katayama M, Sonobe H, Wakabayashi K, Kondo K. (2004) Intake of beer inhibits azoxymethane-induced colonic carcinogenesis in male Fisher 344 rats. International Journal of Cancer, 108, 404-411. (Pubitemid 37549606)
80. Nozawa H, Tazumi K, Sato K, Yoshida A, Takata J, Arimoto-Kobayashi S, Kondo K. (2004) Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon . Mutation Research, 559, 177-187. (Pubitemid 38452929)
81. Arimoto-Kobayashi S, Ishida R, Nakai Y, Idei C, Takata J, Takahashi E, Okamoto K, Negishi T, Konuma T. (2006) Inhibitory effects of beer on mutation in the ames test and DNA adduct formation in mouse organs induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Biological & Pharmaceutical Bulletin, 29, 67-70. (Pubitemid 43036696)
82. Hidestrand M, Shankar K, Ronis MJ, Badger TM. (2005) Effects of light and dark beer on hepatic cytochrome P-450 expression in male rats receiving alcoholic beverages as part of total enteral nutrition. Alcoholism, Clinical and Experimental Research, 29, 888-895. (Pubitemid 40686560)
83. Innes G. (1998) Cost-effectiveness of beer versus red wine for the prevention of symptomatic coronary artery disease. Canadian Medical Association Journal, 159, 1463-1466.
84. Stevens JF, Miranda CL, Frei B, Buhler DR. (2003) Inhibition of peroxynitrite-mediated LDL oxidation of prenylated flavonoids: the αβ-unsaturated keto functionality of 2′-hydroxychalcones as a novel antioxidant pharmacophore. Chemical Research in Toxicology, 16, 1277-1286. (Pubitemid 37315217)
85. Miranda CL, Stevens JF, Ivanov V, McCall M, Frei B, Deinzer ML, Buhler DR. (2000) Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. Journal of Agricultural and Food Chemistry, 48, 3876-3884.
86. Vogel S, Heilmann J. (2008) Synthesis, cytotoxicity and antioxidative activity of minor prenylated chalcones from Humulus lupulus. Journal of Natural Products, 71, 1237-1241.
87. Vogel S, Ohmayer S, Brunner G, Heilmann J. (2008) Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorganic and Medicinal Chemistry, 16, 4286-4293.
88. Vincent AM, Edwards JL, Sadidi M, Feldman EL. (2008) The antioxidant response as a drug target in diabetic neuropathy. Current Drug Targets, 9, 94-109. (Pubitemid 351201684)
89. Guerreiro S, Monteiro R, Martins MJ, Calhau C, Azevedo I, Soares R. (2007) Distinct modulation of alkaline phosphatise isoenzymes by 17β-estradiol and xanthohumol in breast cancer MCF-7 cells. Clinical Biochemistry, 40, 268-273. (Pubitemid 46108701)
90. Monteiro R, Calhau C, Silva AO, Pinheiro-Silva S, Guerreiro S, Gärtner F, Azevedo I, Soares R. (2008) Xanthohumol inhibits inflammatory factor production and angiogenesis in breast cancer xenografts. Journal of Cellular Biochemistry, 104, 1699-1707.
91. Pan L, Becker H, Gerhäuser C. (2005) Xanthohumol induces apoptosis in cultured 40-16 human colon cancer cells by activation of the death receptor-and mitochondrial pathway. Molecular Nutrition & Food Research, 49, 837-843. (Pubitemid 41411567)
92. Goto K, Asai T, Hara S, Namatame I, Tomoda H, Ikemoto M, Oku N. (2005) Enhanced antitumor activity of xanthohumol, a diacylglycerol acyltransferase inhibitor, under hypoxia. Cancer Letters, 219, 215-222. (Pubitemid 40269486)
93. Colgate EC, Miranda CL, Stevens JF, Bray TM, Ho E. (2007) Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-kappaB activation in prostate epithelial cells. Cancer Letters, 246, 201-209.
94. Vanhoecke B, Derycke L, van Marck V, Depypere H, De Keukeleire D, Bracke M. (2005) Antiinvasive effect of xanthohumol, a prenylated chalcone present in hops (Humulus lupulus L.) and beer. International Journal of Cancer, 117, 889-895. (Pubitemid 41688562)
95. Monteghirfo S, Tosetti F, Ambrosini C, Stigliani S, Pozzi S, Frassoni F, Fassina G, Soverini S, Albini A, Ferrari N. (2008) Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-kappaB and p53 modulation. Molecular Cancer Therapeutics, 7, 2692-2702.
96. Koo JH, Kim HT, Yoon HY, Kwon KB, Choi II, Jung SH, Kim HU, Park BH, Park JW. (2008) Effect of xanthohumol on melanogenesis in B16 melanoma cells. Experimental and Molecular Medicine, 40, 313-319.
97. Zanoli P, Zavatti M. (2008) Pharmacognostic and pharmacological profile of Humulus lupulus L. Journal of Ethnopharmacology, 116, 383-396. (Pubitemid 351335198)
98. Kac J, Plazar J, Mlinaric A, Zegura B, Lah TT, Filipic M. (2008) Antimutagenicity of hops (Humulus lupulus L.): bioassay-directed fractionation and isolation of xanthohumol. Phytomedicine, 15, 216-220. (Pubitemid 351232221)
99. Plazar J, Filipic M, Groothuis GM. (2008) Antigenotoxic effect of xanthohumol in rat liver slices. Toxicology in Vitro, 22, 318-327. (Pubitemid 351163537)
100. Delmulle L, Vanden Berghe T, De Keukeleire D, Vandenabeele P. (2008) Treatment of PC-3 and DU145 prostate cancer cells by prenylflavonoids from hop (Humulus lupulus L.) induces a caspase-independent form of cell death. Phytotherapy research, 22, 197-203. (Pubitemid 351363238)
101. Bracke ME, Vanhoecke BW, Derycke L, Bolca S, Possemiers S, Heyerick A, Stevens CV, De Keukeleire D, Depypere HT, Verstraete W, Williams CA, McKenna ST, Tomar S, Sharma D, Prasad AK, DePass AL, Parmar VS. (2008) Plant polyphenolics as anti-invasive cancer agents. Anti-Cancer Agents in Medicinal Chemistry, 8, 171-185. (Pubitemid 351761442)
102. Lee SH, Kim HJ, Lee JS, Lee IS, Kang BY. (2007) Inhibition of topoisomerase I activity and efflux drug transporters' expression by xanthohumol from hops. Archives of Pharmacal Research, 30, 1435-1439.
103. Monteiro R, Faria A, Azevedo I, Calhau C. (2007) Modulation of breast cancer cell survival by aromatase inhibiting hop (Humulus lupulus L.) flavonoids. Journal of Steroid & Molecular Biology, 105, 124-130. (Pubitemid 47211960)
104. Delmulle L, Bellahcène A, Dhooge W, Comhaire F, Roelens F, Huvaere K, Heyerick A, Castronovo V, De Keukeleire D. (2006) Anti-proliferative properties of prenylated flavonoids from hops (Humulus lupulus L.) in human prostate cancer cell lines. Phytomedicine, 13, 732-734. (Pubitemid 44666399)
105. Monteiro R, Becker H, Azevedo I, Calhau C. (2006) Effect of hop (Humulus lupulus L.) flavonoids on aromatase (estrogen synthase) activity. Journal of Agricultural and Food Chemistry, 54, 2938-2943.
106. Radovic B, Schmutzler C, Kohrle J. (2005) Xanthohumol stimulates iodide uptake in rat thyroid-derived FRTL-5 cells. Molecular Nutrition and Food Research, 49, 832-836. (Pubitemid 41411566)
107. Lust S, Vanhoecke B, Janssens A, Philippe J, Bracke M, Offner F. (2005) Xanthohumol kills B-chronic lymphocytic leukemia cells by an apoptotic mechanism. Molecular Nutrition and Food Research, 49, 844-850. (Pubitemid 41411568)
108. Dietz BM, Kang YH, Liu G, Eggler AL, Yao P, Chadwick LR, Pauli GF, Farnsworth NR, Mesecar AD, van Breemen RB, Bolton JL. (2005) Xanthohumol isolated from Humulus lupulus inhibits menadione-induced DNA damage through induction of quinone reductase. Chemical Research in Toxicology, 18, 1296-1305. (Pubitemid 41170254)
109. Zhao F, Nozawa H, Daikonnva A, Kondo K, Kitanaka S. (2003) Inhibitors of nitric oxide production from hops (Humulus lupulus L.). Biological and Pharmaceutical Bulletin, 26, 61-65.
110. Gerhäuser C, Alt AP, Klimo K, Knauft J, Frank N, Becker H. (2002) Isolation and potential cancer chemopreventive activities of phenolic compounds of beer. Phytochemistry Reviews, 1, 369-377. (Pubitemid 41413232)
111. Miranda CL, Yang YH, Henderson MC, Stevens JF, Santana-Rios G, Deinzer ML, Buhler DR. (2000) Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4,5-F] quinoline, mediated by cDNA-expressed human CYP1A2. Drug Metabolism and Disposition, 28, 1297-1302.
112. Henderson MC, Miranda CL, Stevens JF, Deinzer ML, Buhler DR. (2000) In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica, 30, 235-251.
113. Miranda CL, Aponso GL, Stevens JF, Deinzer ML, Buhler DR. (2000) Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells. Cancer Letters, 149, 21-29.
114. Miranda CL, Stevens JF, Helmrich A, Henderson MC, Rodriguez RJ, Yang YH, Deinzer ML, Barnes DW, Buhler DR. (1999) Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food and Chemical Toxicology, 37, 271-285. (Pubitemid 29335754)
115. Plazar J, Zegura B, Lah TT, Filipic M. (2007) Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene (BaP), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and tert-butyl hydroperoxide (t-BOOH) in HepG2 human hepatoma cells. Mutation Research, 632, 1-8. (Pubitemid 47031694)
116. Cho YC, Kim HJ, Kim YJ, Lee KY, Choi HJ, Lee IS, Kang BY. (2008) Differential anti-inflammatory pathway by xanthohumol in IFN-γ and LPS-activated macrophages. International Immunopharmacology, 8, 567-573.
117. Nowakowska Z. (2007) A review of anti-infective and anti-inflammatory chalcones. European Journal of Medicinal Chemistry, 42, 125-137.
118. Tabata N, Ito M, Tomoda H, Omura S. (1997) Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus. Phytochemistry, 46, 683-687. (Pubitemid 27483829)
119. Tomoda H, Omura S. (2007) Potential therapeutics for obesity and atherosclerosis: Inhibitors of neutral lipid metabolism from microorganisms. Pharmacology & Therapeutics, 115, 375-389. (Pubitemid 47362374)
120. Casaschi A, Maiyoh GK, Rubio BK, Li RW, Adeli K, Theriault AG. (2004) The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. Journal of Nutrition, 134, 1340-1346. (Pubitemid 38720704)
121. Hubbard BK, Enyedy I, Gilmore TA, Serrano-Wu MH. (2007) Antisense and small-molecule modulation of diacylglycerol acyltransferase. Expert Opinion on Therapeutic Patents, 17, 1331-1339. (Pubitemid 350186588)
122. Matsuda D, Tomoda H. (2007) DGAT inhibitors for obesity. Current Opinion in Investigational Drugs, 8, 836-841.
123. Albini A, Dell'Eva R, Vene R, Ferrari N, Buhler DR, Noonan DM, Fassina G. (2006) Mechanims of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. The Faseb Journal, 20, 527-529. (Pubitemid 46671238)
124. Mojzis J, Varinska L, Mojzisova G, Kostova I, Mirossay L. (2008) Antiangiogenic effects of flavonoids and chalcones. Pharmacological Research, 57, 259-265.
125. Dell'Eva R, Ambrosini C, Vannini N, Piaggio G, Albini A, Ferrari N. (2007) AKT/NF-kB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer, 110, 2007-2011. (Pubitemid 350036860)
126. Noonan DM, Benelli R, Albini A. (2007) Angiogenesis and cancer prevention: a vision. Recent results in cancer research, 174, 219-224.
127. Bertl E, Klimo K, Heiss E, Klenke F, Peschke P, Becker H, Eicher T, Herhaus C, Kapadia G, Bartsch H, Gerhäuser C. (2004) Identification of novel inhibitors of angiogenesis using a human in vitro antiangiogenic assay. International Journal of Cancer Prevention, 1, 47-61.
128. Natarajan P, Katta S, Andrei I, Babu Rao Ambati V, Leonida M, Haas GJ. (2008) Positive antibacterial co-action between hop (Humulus lupulus) constituents and selected antibiotics. Phytomedicine, 15, 194-201.
129. Hanske L, Hussong R, Frank N, Gerhäuser C, Blaut M, Braune A. (2005) Xanthohumol does not affect the composition of rat intestinal microbiota. Molecular Nutrition and Food Research, 49, 868-873. (Pubitemid 41411572)
130. Bhattacharya S, Virani S, Zavro M, Haas GJ. (2003) Inhibition of Streptococcus mutans and other oral streptococci by hop (Humulus lupulus L.) constituents. Economic Botany, 57, 118-125. (Pubitemid 36821231)
131. Avula B, Ganzera M, Warnick JE, Feltenstein MW, Sufka KJ, Khan IA. (2004) High-performance liquid chromatographic determination of xanthohumol in rat plasma, urine, and fecal samples. Journal of Chromatographic Science, 42, 378-382.
132. Nookandeh A, Frank N, Steiner F, Ellinger R, Schneider B, Gerhäuser C, Becker H. (2004) Xanthohumol metabolites in faeces of rats. Phytochemistry, 65, 561-570.
133. Possemiers S, Heyerick A, Robbens V, De Keukeleire D, Verstraete W. (2005) Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. Journal of Agricultural and Food Chemistry, 53, 6281-6288. (Pubitemid 41169374)
134. Wang Q, Ding ZH, Liu JK, Zheng YT. (2004) Xanthohumol, a novel anti-HIV agent purified from hops Humulus lupulus. Antiviral Research, 64, 189-194. (Pubitemid 39506839)
135. Chattopadhyay D, Khan MT. (2008) Ethnomedicines and ethnomedicinal phytophores against herpesviruses. Biotechnology Annual Review, 14, 297-348. (Pubitemid 351916585)
136. Singh S, Malik BK, Sharma DK. (2007) Targeting HIV-1 through molecular modeling and docking studies of CXCR4: leads for therapeutic development. Chemical Biology and Drug Design, 69, 191-203. (Pubitemid 46608453)
137. Buckwold VE, Wilson RJ, Nalca A, Beer BB, Voss TG, Turpin JA, Buckheit RW, Wei J, Wenzel-Mathers M, Walton EM, Smith RJ, Pallansch M, Ward P, Wells J, Chuvala L, Sloane S, Paulman R, Russell J, Hartman T, Ptak R. (2004) Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Research, 61, 57-62.
138. Mizobuchi S, Sato Y. (1984) A new flavanone with antifungal activity isolated from hops. Agricultural and Biological Chemistry, 48, 2771-2775. (Pubitemid 15181029)
139. Frölich S, Schubert C, Bienzle U, Jenett-Siems K. (2005) In vitro antiplasmodial activity of prenylated chalcone derivatives of hops (Humulus lupulus) and their interaction with haemin. Journal of Antimicrobial Chemotherapy, 55, 883-887. (Pubitemid 40883172)
140. Ginsburg H, Famin O, Zhang J, Krugliak M. (1998) Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of actions. Biochemical Pharmacology, 56, 1305-1313. (Pubitemid 28511267)
141. Herath W, Ferreira D, Khan SI, Khan IA. (2003) Identification and biological activity of microbial metabolites of xanthohumol. Chemical and Pharmaceutical Bulletin, 51, 1237-1240. (Pubitemid 41685577)
142. Ngeh J, Anand V, Gupta S. (2002) Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clinical Microbiology and Infection, 8, 2-13. (Pubitemid 34993754)
143. Virgili F, Scaccini C, Packer L, Rimbach G. (2001) Antioxidants in Food. In Cardiovascular disease and nutritional phenolics. Pokorny N, Yanishlieva N, Gordon M (Ed). Woodhead Publishing Ltd, Cambridge, UK, 87-99.
144. Yang JY, Della-Fera MA, Rayalam S, Baile CA. (2007) Effect of xanthohumol and isoxanthohumol on 3T3-L1 cell apoptosis and adipogenesis. Apoptosis, 12, 1953-1963. (Pubitemid 47498236)
145. Pang Y, Nikolic D, Zhu D, Chadwick LR, Pauli GF, Farnsworth NR, van Breemen RB. (2007) Binding of the hop (Humulus lupulus L.) chalcone xanthohumol to cytosolic proteins in Caco-2 intestinal epithelial cells. Molecular Nutrition & Food Research, 51, 872-879. (Pubitemid 47173697)
146. Shi Y, Burn P. (2004) Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Nature Reviews Drug Discovery, 3, 695-710. (Pubitemid 39173510)
147. Yang JY, Della-Fera MA, Rayalam S, Baile CA. (2008) Enhanced effects of xanthohumol plus honokiol on apoptosis in 3T3-L1 adipocytes. Obesity, 16, 1232-1238. (Pubitemid 351770541)